We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Air Lease, National Energy, Catalyst and JBT Marel
Read MoreHide Full Article
For Immediate Release
Chicago, IL – March 11, 2026 – Stocks in this week’s article are Air Lease (AL - Free Report) , National Energy Services Reunited (NESR - Free Report) , Catalyst Pharmaceuticals (CPRX - Free Report) and JBT Marel Corp. (JBTM - Free Report) .
Geopolitical Volatility Boosts Value Investing: 4 Low-PEG Picks
Amid intensifying geopolitical tensions, AI-driven economic disruption and rising commodity prices, global markets have entered a period of heightened volatility. Gold has surged to record levels as investors seek safe havens during uncertainty and inflation concerns, while equities face correction risks from geopolitical conflicts, oil shocks and elevated valuations.
In such an environment, value investing often becomes attractive because fundamentally strong companies may trade at discounted prices due to broad market fear rather than deteriorating fundamentals. Historically, such dislocations allow patient investors to accumulate cash-generating businesses at lower valuations, positioning portfolios to benefit when macro uncertainty stabilizes and sentiment normalizes.
Here, we discuss four such stocks: Air Lease, National Energy Services Reunited, Catalyst Pharmaceuticals and JBT Marel Corp.
However, this apparently simple value investment technique has some drawbacks, and not understanding the strategy properly may often lead to “value traps.” In such a situation, these value picks start to underperform over the long run as the temporary problems, which once drove the share price down, turn out to be persistent.
There are many value investment yardsticks, such as dividend yield, P/E or P/B, which are simple and can single out whether a stock is trading at a discount.
However, for investors looking to escape such value traps, it is also vital to determine where the stock would be headed in the next 12 to 24 months. Warren Buffett advises these investors to focus on the earnings growth potential of a stock. This is where lies the importance of a not-so-popular value investing metric, the PEG ratio.
PEG Ratio at a Glance
The PEG ratio is defined as (Price/ Earnings)/Earnings Growth Rate
A low PEG ratio is always better for value investors.
While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.
There are some drawbacks to using the PEG ratio. It doesn’t consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.
Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Our PEG-Driven Picks
Here are four stocks that qualified the screening:
Air Lease: Los Angeles, CA-based Air Lease is a leading aircraft leasing company. It is primarily involved in purchasing commercial aircraft directly from manufacturers and leasing the same to its airline customers across the globe. Some noteworthy manufacturers that the company works with are The Boeing Company and Airbus S.A.S.
AL currently has a Zacks Rank #2 and a Value Score of A. Air Lease also has an impressive five-year expected growth rate of 17.3%.
National Energy Services: The company provides oilfield services across the Middle East and North Africa. Its Production Services segment offers hydraulic fracturing, coiled tubing, cementing, nitrogen and stimulation services, along with production chemicals, artificial lift, safety systems and water treatment solutions. The Drilling and Evaluation Services segment supplies drilling and workover rigs, directional drilling, drilling fluids, wireline and slickline services, well testing and various drilling tools, wellhead products and intervention solutions.
NESR currently has a Zacks Rank #1 and a Value Score of B. National Energy Services also has an impressive five-year expected growth rate of 23%.
Catalyst Pharmaceuticals: Coral Gables, FL-based Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases. In October 2012, Catalyst Pharmaceuticals licensed U.S. rights to Firdapse (amifampridine phosphate) from BioMarin Pharmaceutical. The drug is approved in the EU, United States, Canada and Japan for treating Lambert-Eaton Myasthenic Syndrome in adults, with patents protecting it through 2037.
Apart from a discounted PEG and P/E, Catalyst Pharmaceuticals currently has a Zacks Rank #1 and a Value Score of A. CPRX has a long-term historical growth rate of 46.4%.
JBT Marel: It provides technology solutions for the food and beverage industry across North America, Europe, the Middle East, Africa, Asia Pacific and Latin America. Operating through Protein Solutions and Prepared Food and Beverage Solutions, the company supplies equipment, software and services for food processing.
JBT Marel has a Zacks Rank #2 and a Value Score of B. JBTM also has an impressive five-year historical growth rate of 11.5%.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Zacks.com featured highlights include Air Lease, National Energy, Catalyst and JBT Marel
For Immediate Release
Chicago, IL – March 11, 2026 – Stocks in this week’s article are Air Lease (AL - Free Report) , National Energy Services Reunited (NESR - Free Report) , Catalyst Pharmaceuticals (CPRX - Free Report) and JBT Marel Corp. (JBTM - Free Report) .
Geopolitical Volatility Boosts Value Investing: 4 Low-PEG Picks
Amid intensifying geopolitical tensions, AI-driven economic disruption and rising commodity prices, global markets have entered a period of heightened volatility. Gold has surged to record levels as investors seek safe havens during uncertainty and inflation concerns, while equities face correction risks from geopolitical conflicts, oil shocks and elevated valuations.
In such an environment, value investing often becomes attractive because fundamentally strong companies may trade at discounted prices due to broad market fear rather than deteriorating fundamentals. Historically, such dislocations allow patient investors to accumulate cash-generating businesses at lower valuations, positioning portfolios to benefit when macro uncertainty stabilizes and sentiment normalizes.
Here, we discuss four such stocks: Air Lease, National Energy Services Reunited, Catalyst Pharmaceuticals and JBT Marel Corp.
However, this apparently simple value investment technique has some drawbacks, and not understanding the strategy properly may often lead to “value traps.” In such a situation, these value picks start to underperform over the long run as the temporary problems, which once drove the share price down, turn out to be persistent.
There are many value investment yardsticks, such as dividend yield, P/E or P/B, which are simple and can single out whether a stock is trading at a discount.
However, for investors looking to escape such value traps, it is also vital to determine where the stock would be headed in the next 12 to 24 months. Warren Buffett advises these investors to focus on the earnings growth potential of a stock. This is where lies the importance of a not-so-popular value investing metric, the PEG ratio.
PEG Ratio at a Glance
The PEG ratio is defined as (Price/ Earnings)/Earnings Growth Rate
A low PEG ratio is always better for value investors.
While P/E alone fails to identify a true value stock, PEG helps find the intrinsic value of a stock.
There are some drawbacks to using the PEG ratio. It doesn’t consider the very common situation of changing growth rates, such as the forecast of the first three years at a very high growth rate, followed by a sustainable but lower growth rate over the long term.
Hence, PEG-based investing can turn out to be even more rewarding if some other relevant parameters are also taken into consideration.
Our PEG-Driven Picks
Here are four stocks that qualified the screening:
Air Lease: Los Angeles, CA-based Air Lease is a leading aircraft leasing company. It is primarily involved in purchasing commercial aircraft directly from manufacturers and leasing the same to its airline customers across the globe. Some noteworthy manufacturers that the company works with are The Boeing Company and Airbus S.A.S.
AL currently has a Zacks Rank #2 and a Value Score of A. Air Lease also has an impressive five-year expected growth rate of 17.3%.
National Energy Services: The company provides oilfield services across the Middle East and North Africa. Its Production Services segment offers hydraulic fracturing, coiled tubing, cementing, nitrogen and stimulation services, along with production chemicals, artificial lift, safety systems and water treatment solutions. The Drilling and Evaluation Services segment supplies drilling and workover rigs, directional drilling, drilling fluids, wireline and slickline services, well testing and various drilling tools, wellhead products and intervention solutions.
NESR currently has a Zacks Rank #1 and a Value Score of B. National Energy Services also has an impressive five-year expected growth rate of 23%.
Catalyst Pharmaceuticals: Coral Gables, FL-based Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases. In October 2012, Catalyst Pharmaceuticals licensed U.S. rights to Firdapse (amifampridine phosphate) from BioMarin Pharmaceutical. The drug is approved in the EU, United States, Canada and Japan for treating Lambert-Eaton Myasthenic Syndrome in adults, with patents protecting it through 2037.
Apart from a discounted PEG and P/E, Catalyst Pharmaceuticals currently has a Zacks Rank #1 and a Value Score of A. CPRX has a long-term historical growth rate of 46.4%.
JBT Marel: It provides technology solutions for the food and beverage industry across North America, Europe, the Middle East, Africa, Asia Pacific and Latin America. Operating through Protein Solutions and Prepared Food and Beverage Solutions, the company supplies equipment, software and services for food processing.
JBT Marel has a Zacks Rank #2 and a Value Score of B. JBTM also has an impressive five-year historical growth rate of 11.5%.
Click here to sign up for a free trial to the Research Wizard today.
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2881828/geopolitical-volatility-boosts-value-investing-4-low-peg-picks
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.